Login / Signup
Huiyong Zhao
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
2025
2016
Top Topics
2025
2016
Cancer Therapy
2025
2016
Epithelial Mesenchymal Transition
2025
2016
Pi K Akt
2025
2016
Inflammatory Response
Top Venues
Cell death discovery
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Huiyong Zhao
,
Sheng Wei
,
Dachen Zhou
,
Yongfan Liu
,
Zicheng Guo
,
Chuibao Fang
,
Xiaoxi Pang
,
Fei Li
,
Hui Hou
,
Xiao Cui
Blocking the CXCL1-CXCR2 axis enhances the effects of doxorubicin in HCC by remodelling the tumour microenvironment via the NF-κB/IL-1β/CXCL1 signalling pathway.
Cell death discovery
9 (1) (2023)